TAG:
lab executive
Several Labs Planning A Public Stock Offering
CEO SUMMARY: During the past six years, no general clinical laboratory company has undergone an initial public stock offering (IPO). That will certainly change during the next 24 months. There are several private lab companies which want to go public. But this business strategy can only s…
Express Scripts, InformInvestor.com, UroCor, Bio-Reference Laboratories
PRESCRIPTION DRUG SPENDING HITS A RECORD INCREASE OF 17.4% IN 1999 Just-released data from Express Scripts, Inc. indicates that spending on prescription drugs increased by a record 17.4% during 1999. This compares to a 9.6% spending increase for drugs in 1998. As most lab e…
“July 10, 2000 Intelligence: Late Breaking Lab News”
When it comes to laboratory information services, the Internet may indeed be a competitive leveler. THE DARK REPORT is tracking a host of small software companies that already have working solutions for Web-enabled lab test ordering and results reporting installed and operating in the field. It seems…
Labs Should Leverage Their “Crown Jewels”
ONE NEW FEATURE of our annual Executive War College every May is a Lab CEO SUMMIT which takes place on the Thursday after the Tuesday-Wednesday event. It attracts a growing number of senior lab executives and pathologists who come to explore the strategic directions of the lab industry and p…
BRLI Ready To Leverage Physician Relationship
CEO SUMMARY: As healthcare E-commerce rapidly approaches, clinical laboratories will find they have a built-in competitive advantage—their existing business relationship and communication links to physician offices. Bio-Reference Laboratories, Inc. is moving rapidly to capitalize on thi…
War College Identifies Emerging Lab Trends
CEO SUMMARY: Disruptive technologies and the arrival of healthcare E-commerce were two common themes which emerged from this year’s Executive War College on Laboratory and Pathology Management. Consensus by faculty and attendees alike was that every lab organization should have an Inter…
Luminex Raises $83 Mil In Public Stock Offering
CEO SUMMARY: During the past year, Luminex Corporation moved swiftly to push its LabMAP™ multiplex testing technology into the bioassay marketplace. It found high interest among companies in the pharmaceutical, diagnostics, and bioresearch industries. Luminex executives say that a numbe…
Shared Lab Organizations Evolving Into New Forms
CEO SUMMARY: For two decades, the limited number of laboratory joint ventures that appeared were invariably partnerships between commercial labs and hospital labs. Today’s hostile healthcare environment makes it tougher for these types of joint ventures to prosper and meet the needs all…
Humana Denies Payment For Pathology CPT Codes
CEO SUMMARY: It’s not just the Medicare program that wants to eat away at the reimbursement for laboratory tests. Private payers continue to seek ways to cut back reimbursement to laboratory providers. The latest attack is on two surgical pathology codes—88300 and 88302. In at least t…
2000’s Movers & Shakers Represent Strong Leaders
CEO SUMMARY: Its time again for THE DARK REPORT to make its yearly selection of the lab industry’s Movers & Shakers. Individuals chosen for 2000 represent a cross section of laboratory companies. Their successes demonstrate that leadership and vision continue to make a difference, d…
CURRENT ISSUE
Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.